PATH | VRL
Menu

Find resources

Total results with these characteristics: 1187

Topic: Disease/vaccine specific information

Page 8 of 60
Conducting Vaccine Clinical Trials in Sub-Saharan Africa: Operational Challenges and Lessons Learned From the Meningitis Vaccine Project

The Meningitis Vaccine Project (MVP) was established with the goal of developing, testing, licensing, and introducing an affordable group A meningococcal conjugate vaccine for Africa. The authors of this article, published in Vaccine, describe the …

Author: Marchetti E, Mazarin-Diop V, Chaumont J, et al.

Publication date: 2012

Confirmation of Japanese Encephalitis as an Endemic Human Disease Through Sentinel Surveillance in Indonesia

Japanese encephalitis (JE) results in significant mortality and disability in children in Asia. In Indonesia, despite recognition of JE virus transmission, reports of human disease have been few and from limited geographic areas. Hospital-based …

Author: Ompusunggu S, Hills S, Sembiring Maha M, et al.

Publication date: 2008

Conjugate Vaccine Introduction in the African Meningitis Belt: Meeting Surveillance Objectives

This article, published in Tropical Medicine & International Health, asserts that surveillance systems and techniques for diagnosing bacterial meningitis and pneumococcal disease in the African meningitis belt have improved greatly over the …

Author: Mueller JE

Publication date: 2013

Conjugate Vaccines

This review, published in Expert Review of Vaccines, looks at what has been learned from developing conjugate vaccines against Haemophilus influenzae type b, Streptococcus pneumoniae, and group C Neisseria meningitidis that could be useful for the …

Author: Lockhart S

Publication date: 2003

Conservation and Immunogenicity of Novel Antigens in Diverse Isolates of Enterotoxigenic Escherichia coli

This article, published in PLoS Neglected Tropical Diseases, reports on a study that aimed to identify protective antigens shared by many enterotoxigenic Escherichia coli (ETEC) strains to help inform the development of new vaccine candidates. Using …

Author: Luo Q, Qadri F, Kansal R, Rasko DA, Sheikh A, Fleckenstein JM

Publication date: 2015

Considerations for a Phase III Trial to Evaluate a Group B Streptococcus Polysaccharide-Protein Conjugate Vaccine in Pregnant Women for the Prevention of Early- and Late-Onset Invasive Disease in Young Infants

This article, published in Vaccine, discusses the global disease burden of group B Streptococcus (GBS) and strategies to combat the disease. The authors argue that vaccination is a promising strategy, particularly in low-income countries where …

Author: Madhi SA, Dangor Z, Heath PT, et al.

Publication date: 2013

The Contribution of Specific Pneumococcal Serogroups to Different Disease Manifestations: Implications for Conjugate Vaccine Formulation and Use, Part II

To assess whether certain serogroups of Streptococcus pneumoniae are preferentially associated with specific disease manifestations, we analyzed all recent pneumococcal disease studies and assessed the relative frequency of isolation of each …

Author: Hausdorff WP, Bryant J, Paradiso P, Siber G

Publication date: 2000

Control of Epidemic Meningococcal Disease. WHO Practical Guidelines. 2nd Edition

These guidelines, designed for physicians, laboratory workers, and health care administrators, provide comprehensive information on epidemiology and standard techniques for diagnosis, treatment, prevention, and control of meningococcal disease …

Author: World Health Organization

Publication date: 1998

Control of Japanese Encephalitis in Asia: The Time is Now

This editorial, published in Expert Review of Anti-infective Therapy, discusses recent progress in the development and availability of improved Japanese encephalitis vaccines to reduce the morbidity and mortality of the disease. ABSTRACT …

Author: Hills S, Martin R, Marfin A, Fischer M

Publication date: 2014

Control of Japanese Encephalitis--Within Our Grasp?

The article, from the New England Journal of Medicine, provides an up-to-date summary of JE disease incidence, epidemiology, and vaccines against JE.

Author: Solomon T

Publication date: 2006

Coordinated Surveillance and Detection of Pneumococcal and Haemophilus influenzae type b (Hib) Disease in Developing Countries

This supplemental issue of Clinical Infectious Diseases provides numerous articles on the surveillance and detection of pneumococcal and Haemophilus influenzae type b disease in developing countries. Topics include progress and challenges in disease …

Author: Black S, Knoll MD, eds.

Publication date: 2009

Correlates of Immunity to Respiratory Syncytial Virus (RSV) Associated-Hospitalization: Establishment of Minimum Protective Threshold Levels of Serum Neutralizing Antibodies

This article, published in Vaccine, reports on a study to determine if respiratory syncytial virus (RSV) specific, serum antibody titers correlate with protection against RSV-associated hospitalization at all ages. The authors identified a minimal …

Author: Piedra PA, Jewell AM, Cron SG, Atmar RL, Glezen WP

Publication date: 2003

Correlates of Protection: Novel Generations of Influenza Vaccines

This article, published in the journal Vaccine, reviews potential correlates of protection against influenza and discusses some of the vaccination strategies that could result in optimal protection against epidemic and pandemic influenza. ABSTRACT …

Author: Rimmelzwaan GF, McElhaney JE

Publication date: 2008

The Cost and Public Health Burden of Invasive Meningococcal Disease Outbreaks: A Systematic Review

Invasive meningococcal disease (IMD) is a serious disease with a rapid onset, high mortality rate, and risk of long-term complications. The authors of this article, published in Pharmacoeconomics, systematically reviewed the literature on the costs …

Author: Anonychuk A, Woo G, Vyse A, Demarteau N, Tricco AC

Publication date: 2013

A Cost Comparison of Introducing and Delivering Pneumococcal, Rotavirus and Human Papillomavirus Vaccines in Rwanda

This article, published in Vaccine, reports on a cost comparison of introducing multiple vaccines in a single country and then assessing the financial and economic impact at the time and implications for the future. The objective of the analysis was …

Author: Ngabo F, Levin A, Wang SA, et al.

Publication date: 2015

A Cost Effectiveness and Capacity Analysis for the Introduction of Universal Rotavirus Vaccination in Kenya: Comparison Between Rotarix and RotaTeq Vaccines

The authors of this article, published in PLoS ONE, applied cost-effectiveness modeling and a cold-chain impact assessment to aid decision-making on rotavirus vaccine introduction in Kenya. They conclude that use of either vaccine is cost-effective, …

Author: van Hoek AJ, Ngama M, Ismail A, et al.

Publication date: 2012

The Cost of Cervical Cancer Prevention in Low- and Lower-Middle-Income Countries

This briefing paper discusses estimates of the cost and health impact of cervical cancer prevention (including human papillomavirus vaccination, screening, and preventive treatment) in countries with a per capita gross domestic product less than …

Author: Cervical Cancer Action

Publication date: 2017

Cost-Effectiveness Analysis of Typhoid Conjugate Vaccines in Five Endemic Low- and Middle-Income Settings

Typhoid fever remains endemic in low- and middle-income countries, yet programmatic use of existing vaccines is limited. This article, published in Vaccine, evaluates the cost-effectiveness of five typhoid conjugate vaccine (TCV) delivery strategies …

Author: Antillón M, Bilcke J, Paltiel AD, Pitzer VE

Publication date: 2017

Cost-Effectiveness of a New Rotavirus Vaccination Program in Pakistan: A Decision Tree Model

This article, published in Vaccine, reports on the expected public health impact of a national rotavirus vaccination program in Pakistan by performing a cost-effectiveness study from the perspective of the health care system. Across a range of …

Author: Patel HD, Roberts ET, Constenla DO

Publication date: 2013

Cost-Effectiveness of a Potential Group B Streptococcal Vaccine Program for Pregnant Women in South Africa

No licensed vaccine for group B Streptococcus (GBS) currently exists, but a polysaccharide-protein conjugate vaccine candidate is currently in trials. This article, published in Vaccine, reports the results of a study that evaluated the potential …

Author: Kim S-Y, Russell LB, Park J, et al.

Publication date: 2014

Page 8 of 60